Skip to main content

Table 1 Demographics, clinical, and substance use characteristics (n = 20)

From: A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies

Variable

Interviewed n = 20 (%)

Age (mean ± SD)

41.5 ± 9

Age (median, IQR)

42.5, 11

Male sex

14 (70)

Female sex

6 (30)

Gender “other”

3 (15)

Racea

 White

12 (60)

 Black

6 (30)

 American Indian/Alaska Native

2 (10)

 Hispanic/Latino

4 (20)

 Preferred not to answer

1 (5)

Other demographics (yes)

 Unemployed

13 (65)

 Currently homeless

8 (40)

 Living in a home or apartment alone

8 (40)

 Living in a home or apartment with others

4 (20)

Highest level of education

 Completed more than high school

9 (43)

Has medical insurance (yes)

19 (95)

Comorbidities and co-use

 Anxiety and/or depression in the past 2 weeks

18 (90)

Current substance use (30 days)

 Smoke cigarettes or vape e-cigarettes (yes)

15 (75)

 Drink alcohol (yes)

10 (50)

 Heroin (yes)

9 (45)

 Injected in the last month (yes)

13 (65)

  1. aParticipants can select more than one answer